2025-01-012026-06-302026-06-30false14890948BARIATRIC SOLUTIONS UK LIMITED2026-07-08falseiso4217:GBPxbrli:pure148909482024-12-31148909482026-06-30148909482025-01-012026-06-30148909482023-12-31148909482024-12-31148909482024-01-012024-12-3114890948bus:SmallEntities2025-01-012026-06-3014890948bus:AuditExempt-NoAccountantsReport2025-01-012026-06-3014890948bus:AbridgedAccounts2025-01-012026-06-3014890948bus:PrivateLimitedCompanyLtd2025-01-012026-06-3014890948core:WithinOneYear2026-06-3014890948core:AfterOneYear2026-06-3014890948core:WithinOneYear2024-12-3114890948core:AfterOneYear2024-12-3114890948core:ShareCapital2026-06-3014890948core:SharePremium2026-06-3014890948core:RevaluationReserve2026-06-3014890948core:OtherReservesSubtotal2026-06-3014890948core:RetainedEarningsAccumulatedLosses2026-06-3014890948core:ShareCapital2024-12-3114890948core:SharePremium2024-12-3114890948core:RevaluationReserve2024-12-3114890948core:OtherReservesSubtotal2024-12-3114890948core:RetainedEarningsAccumulatedLosses2024-12-3114890948core:LandBuildings2026-06-3014890948core:PlantMachinery2026-06-3014890948core:Vehicles2026-06-3014890948core:FurnitureFittings2026-06-3014890948core:OfficeEquipment2026-06-3014890948core:NetGoodwill2026-06-3014890948core:IntangibleAssetsOtherThanGoodwill2026-06-3014890948core:ListedExchangeTraded2026-06-3014890948core:UnlistedNon-exchangeTraded2026-06-3014890948core:LandBuildings2024-12-3114890948core:PlantMachinery2024-12-3114890948core:Vehicles2024-12-3114890948core:FurnitureFittings2024-12-3114890948core:OfficeEquipment2024-12-3114890948core:NetGoodwill2024-12-3114890948core:IntangibleAssetsOtherThanGoodwill2024-12-3114890948core:ListedExchangeTraded2024-12-3114890948core:UnlistedNon-exchangeTraded2024-12-3114890948core:LandBuildings2025-01-012026-06-3014890948core:PlantMachinery2025-01-012026-06-3014890948core:Vehicles2025-01-012026-06-3014890948core:FurnitureFittings2025-01-012026-06-3014890948core:OfficeEquipment2025-01-012026-06-3014890948core:NetGoodwill2025-01-012026-06-3014890948core:IntangibleAssetsOtherThanGoodwill2025-01-012026-06-3014890948core:ListedExchangeTraded2025-01-012026-06-3014890948core:UnlistedNon-exchangeTraded2025-01-012026-06-3014890948core:MoreThanFiveYears2025-01-012026-06-3014890948core:Non-currentFinancialInstruments2026-06-3014890948core:Non-currentFinancialInstruments2024-12-3114890948dpl:CostSales2025-01-012026-06-3014890948dpl:DistributionCosts2025-01-012026-06-3014890948core:LandBuildings2025-01-012026-06-3014890948core:PlantMachinery2025-01-012026-06-3014890948core:Vehicles2025-01-012026-06-3014890948core:FurnitureFittings2025-01-012026-06-3014890948core:OfficeEquipment2025-01-012026-06-3014890948dpl:AdministrativeExpenses2025-01-012026-06-3014890948core:NetGoodwill2025-01-012026-06-3014890948core:IntangibleAssetsOtherThanGoodwill2025-01-012026-06-3014890948dpl:GroupUndertakings2025-01-012026-06-3014890948dpl:ParticipatingInterests2025-01-012026-06-3014890948dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012026-06-3014890948core:ListedExchangeTraded2025-01-012026-06-3014890948dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012026-06-3014890948core:UnlistedNon-exchangeTraded2025-01-012026-06-3014890948dpl:CostSales2024-01-012024-12-3114890948dpl:DistributionCosts2024-01-012024-12-3114890948core:LandBuildings2024-01-012024-12-3114890948core:PlantMachinery2024-01-012024-12-3114890948core:Vehicles2024-01-012024-12-3114890948core:FurnitureFittings2024-01-012024-12-3114890948core:OfficeEquipment2024-01-012024-12-3114890948dpl:AdministrativeExpenses2024-01-012024-12-3114890948core:NetGoodwill2024-01-012024-12-3114890948core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3114890948dpl:GroupUndertakings2024-01-012024-12-3114890948dpl:ParticipatingInterests2024-01-012024-12-3114890948dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3114890948core:ListedExchangeTraded2024-01-012024-12-3114890948dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3114890948core:UnlistedNon-exchangeTraded2024-01-012024-12-3114890948core:NetGoodwill2026-06-3014890948core:IntangibleAssetsOtherThanGoodwill2026-06-3014890948core:LandBuildings2026-06-3014890948core:PlantMachinery2026-06-3014890948core:Vehicles2026-06-3014890948core:FurnitureFittings2026-06-3014890948core:OfficeEquipment2026-06-3014890948core:AfterOneYear2026-06-3014890948core:WithinOneYear2026-06-3014890948core:ListedExchangeTraded2026-06-3014890948core:UnlistedNon-exchangeTraded2026-06-3014890948core:ShareCapital2026-06-3014890948core:SharePremium2026-06-3014890948core:RevaluationReserve2026-06-3014890948core:OtherReservesSubtotal2026-06-3014890948core:RetainedEarningsAccumulatedLosses2026-06-3014890948core:NetGoodwill2024-12-3114890948core:IntangibleAssetsOtherThanGoodwill2024-12-3114890948core:LandBuildings2024-12-3114890948core:PlantMachinery2024-12-3114890948core:Vehicles2024-12-3114890948core:FurnitureFittings2024-12-3114890948core:OfficeEquipment2024-12-3114890948core:AfterOneYear2024-12-3114890948core:WithinOneYear2024-12-3114890948core:ListedExchangeTraded2024-12-3114890948core:UnlistedNon-exchangeTraded2024-12-3114890948core:ShareCapital2024-12-3114890948core:SharePremium2024-12-3114890948core:RevaluationReserve2024-12-3114890948core:OtherReservesSubtotal2024-12-3114890948core:RetainedEarningsAccumulatedLosses2024-12-3114890948core:NetGoodwill2023-12-3114890948core:IntangibleAssetsOtherThanGoodwill2023-12-3114890948core:LandBuildings2023-12-3114890948core:PlantMachinery2023-12-3114890948core:Vehicles2023-12-3114890948core:FurnitureFittings2023-12-3114890948core:OfficeEquipment2023-12-3114890948core:AfterOneYear2023-12-3114890948core:WithinOneYear2023-12-3114890948core:ListedExchangeTraded2023-12-3114890948core:UnlistedNon-exchangeTraded2023-12-3114890948core:ShareCapital2023-12-3114890948core:SharePremium2023-12-3114890948core:RevaluationReserve2023-12-3114890948core:OtherReservesSubtotal2023-12-3114890948core:RetainedEarningsAccumulatedLosses2023-12-3114890948core:AfterOneYear2025-01-012026-06-3014890948core:WithinOneYear2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012026-06-3014890948core:Non-currentFinancialInstrumentscore:CostValuation2026-06-3014890948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-06-3014890948core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3114890948core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3114890948core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3114890948bus:Director12025-01-012026-06-3014890948bus:Director22025-01-012026-06-30

BARIATRIC SOLUTIONS UK LIMITED

Registered Number
14890948
(England and Wales)

Unaudited Financial Statements for the Period ended
30 June 2026

BARIATRIC SOLUTIONS UK LIMITED
Company Information
for the period from 1 January 2025 to 30 June 2026

Directors

MILLER, Geoffrey Edward
VAN DER VEEK, Arnoldinus Carolus Martijn

Company Secretary

EBS CORPORATE SERVICES LIMITED

Registered Address

Innovation Centre
Gallows Hill
Warwick
CV34 6UW

Registered Number

14890948 (England and Wales)
BARIATRIC SOLUTIONS UK LIMITED
Balance Sheet as at
30 June 2026

Notes

30 Jun 2026

31 Dec 2024

£

£

£

£

Called up share capital not paid75,000
Fixed assets
Tangible assets312817,673
12817,673
Current assets
Debtors9,84145,260
Cash at bank and on hand19,62410,805
29,46556,065
Creditors amounts falling due within one year(9,538)(6,936)
Net current assets (liabilities)19,93454,129
Total assets less current liabilities20,06271,802
Creditors amounts falling due after one year-(60,600)
Net assets20,06211,202
Capital and reserves
Called up share capital75,000
Profit and loss account20,0556,202
Shareholders' funds20,06211,202
The financial statements were approved and authorised for issue by the Board of Directors on 8 July 2026, and are signed on its behalf by:
MILLER, Geoffrey Edward
Director
VAN DER VEEK, Arnoldinus Carolus Martijn
Director

Registered Company No. 14890948
BARIATRIC SOLUTIONS UK LIMITED
Notes to the Financial Statements
for the period ended 30 June 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Vehicles5
Office Equipment3
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20262024
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 January 2522,814
Disposals(21,665)
At 30 June 261,149
Depreciation and impairment
At 01 January 255,141
Charge for year5,630
On disposals(9,750)
At 30 June 261,021
Net book value
At 30 June 26128
At 31 December 2417,673
4.Related party transactions
During the period the company had made sales of £15,343 (2024: £9,013) to Bariatric Solutions GmbH and £229,529 (2024: £199,782) to Bariatric Solutions International GmbH.
5.Controlling party
Q Medical International AG is regarded by the directors as being the controlling party by virtue of their 100% shareholding in the company. The company's address is: Kaltenbacherstrasse 24 8260 Stein am Rhein Switzerland